Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunction.
about
Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosuresHow is organ transplantation depicted in internal medicine and transplantation journals.Late kidney allograft loss: what we know about it, and what we can do about itFunctional and histological improvement after everolimus rescue of chronic allograft dysfunction in renal transplant recipients.Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effectsIs aprotinin safe to use in a cohort at increased risk for thrombotic events: results from a randomized, prospective trial in off-pump coronary artery bypass.Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients.Considerations in sirolimus use in the early and late post-transplant periods.Clinical application of mTORi based immunosuppression for renal transplantation in India.An evaluation of sirolimus in renal transplantation.Adverse events associated with mTOR inhibitors.Calcineurin inhibitor sparing strategies in renal transplantation, part one: Late sparing strategies.mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions.Renal function to 5 years after late conversion of kidney transplant patients to everolimus: a randomized trial.
P2860
Q28482115-78B5C278-2DE2-4D65-A00F-575BADFB22E6Q35039284-85CAACD4-2F89-498B-9E18-7665F83524A0Q35153318-558D0ED0-3BB3-4A69-961C-DCD0F8648CD4Q35653607-14EA350C-AD8C-463F-8F93-C4C0A401EB7AQ36938848-4A665159-AEBA-42FA-868A-92B24CDDDC2CQ37113633-48BBA085-B64A-4B62-85E9-0D6B57985E74Q37176562-32DD96D8-5A04-435C-AB06-7E3C3415742DQ37517602-9855026F-3C54-4755-A5AC-BB30B96DD681Q37929851-8B867185-A34F-4DB3-8D0E-7F039320F6BEQ38038696-F4F2DD16-8B55-46EB-A5F1-0FFF6A246CFAQ38068519-8B2A3E02-5520-4E14-BDCE-B583F38FB6D8Q38230449-19C0777D-96DC-4A5E-9E42-DB5CA9BF8ECFQ38962103-C6AEED56-DC6D-4066-A9BD-B1291D59DF5EQ52874072-D5D5D12F-1331-4BFC-A167-B2008BA7D908
P2860
Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunction.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Early withdrawal of calcineuri ...... e to severe renal dysfunction.
@en
Early withdrawal of calcineuri ...... e to severe renal dysfunction.
@nl
type
label
Early withdrawal of calcineuri ...... e to severe renal dysfunction.
@en
Early withdrawal of calcineuri ...... e to severe renal dysfunction.
@nl
prefLabel
Early withdrawal of calcineuri ...... e to severe renal dysfunction.
@en
Early withdrawal of calcineuri ...... e to severe renal dysfunction.
@nl
P2093
P2860
P1476
Early withdrawal of calcineuri ...... e to severe renal dysfunction.
@en
P2093
B Philosophe
C Drachenberg
J Nogueira
J Papadimitriou
P2860
P304
P356
10.1111/J.1600-6143.2007.01825.X
P407
P577
2007-06-01T00:00:00Z